Report copyright - Hematology/Oncology Fellow Fox Chase Cancer Center ......– SWOG 1406 preliminary data at 2017 ASCO –median PFS 4.4 vs 2.0 months and ORR 16% vs 4% in triplet compared to irinotecan
Please pass captcha verification before submit form